Playback speed
10 seconds
ASCO® 2023 Insights: "A Single-Arm, Open-Label Phase 2 Trial of Doxorubicin + Zalifrelimab With Balstilimab in Pts With Advanced/Metastatic Soft Tissue Sarcomas"
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Breelyn Wilky
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Breelyn Wilky
111 views
June 8, 2023
Login to view comments.
Click here to Login